HLA-E polymorphisms in hematopoietic stem cell transplantation

Tissue Antigens

Volumn 79, Issue 4, 2012, Pages 287-290

  Furst D ^a,b   Bindja, J ^a,b   Arnold, R ^c   Herr, W ^d   Schwerdtfeger, R ^e   Muller C H ^f,g   Recker, K ^a,b   Schrezenmeier, H ^a,b   Mytilineos, J ^a,b,g  

^a German Red Cross Blood Transfusion Service Baden Württemberg Hessen and University Hospital Ulm   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e DKD Wiesbaden   (Germany)

^f ZKRD German National Bone Marrow Donor Registry   (Germany)

^g DRST German Registry for Stem Cell Transplantation   (Germany)

Author keywords

CD94; Hematopoietic stem cell transplantation; HLA E; HSCT; Natural killer cell; NKG2A

Indexed keywords

HLA E ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ARTICLE; CELL SURFACE; DISEASE FREE SURVIVAL; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RELAPSE;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; TREATMENT OUTCOME;

EID: 84857785674     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01832.x     Document Type: Article

References (13)

1. Boucraut J, Guillaudeux T, Alizadeh M et al. HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR. Immunogenetics 1993: 38: 117-30.
2. Braud V, Jones EY, McMichael A. The human major histocompatibility complex class I b molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 1997: 27: 1164-9.
3. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998: 391: 795-9.
4. Ulbrecht M, Couturier A, Martinozzi S et al. Cell surface expression of HLA-E: interaction with human beta2-microglobulinand allelic differences. Eur J Immunol 1999: 29: 537-47.
5. Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 2003: 278: 5082-90.
6. Tamouza R, Rocha V, Busson M et al. Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation. Transplantation 2005: 80: 140-4.
7. Danzer M, Polin H, Pröll J et al. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation. Transplantation 2009: 88: 528-32.
8. Tamouza R, Busson M, Rocha V et al. Homozygous status for HLA-E*0103 confers protection from acute graft-vs-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation. Transplantation 2006: 82: 1436-40.
9. Grimsley C, Kawasaki A, Gassner C et al. Definitive high resolution typing of HLA-E allelic polymorphisms: identifying potential errors in existing allele data. Tissue Antigens 2002: 60: 206-12.
10. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA 1999: 94: 496-509.
11. Katsahian S, Resche-Rigon M, Chevret S, Porcher R. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution. Stat Med 2006: 25: 4267-78.
12. Couban S, Simpson DR, Barnett MJ, et al; Canadian Bone Marrow Transplant Group. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002: 100: 1525-31.
13. Ludajic K, Rosenmayr A, Fae I et al. Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors. Transplantation 2009: 88: 1227-8.